Literature DB >> 21802024

Herbal medicine treatment reduces inflammation in a murine model of cockroach allergen-induced asthma.

Jiyoun Kim1, Sudha Natarajan, Hyunsu Bae, Sung-Ki Jung, William Cruikshank, Daniel G Remick.   

Abstract

BACKGROUND: Asthma is a significant disease among children, and its prevalence has increased notably during the last 2 decades. A traditional Korean medicine, So-Cheong-Ryong-Tang (SCRT), has been used for the treatment of asthma in Asia for centuries, but its mechanism for reducing bronchopulmonary inflammation in asthma has yet to be elucidated.
OBJECTIVE: To investigate whether the herbal extract SCRT inhibits inflammation in a mouse model of cockroach allergen-induced asthma.
METHODS: A house dust extract containing endotoxin and cockroach allergens was used for immunization and 2 additional pulmonary challenges in BALB/c mice. Mice were treated with SCRT or vehicle 1 hour before each pulmonary challenge. Respiratory parameters were evaluated by whole-body plethysmography and forced oscillation methods 24 hours after the last challenge. Bronchoalveolar lavage (BAL) fluid was collected, and histologic sections of lung were prepared either 4 or 24 hours after the last house dust extract challenge.
RESULTS: SCRT treatment significantly reduced the hyperreactivity of the airways as measured by whole-body plethysmography and direct measurement of airway resistance. Inflammation was significantly inhibited by SCRT treatment as demonstrated by reduced plasma IgE levels and improved pulmonary histologic characteristics. SCRT significantly reduced the number of neutrophils in the BAL fluid and also significantly reduced the BAL levels of CXC chemokines, providing a potential mechanism for the reduced inflammation. In a similar fashion, SCRT reduced eosinophil recruitment and BAL levels of eotaxin and RANTES.
CONCLUSION: These data indicate that SCRT treatment alleviates asthma-like pulmonary inflammation via suppression of specific chemokines.
Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802024      PMCID: PMC3672053          DOI: 10.1016/j.anai.2011.05.001

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  46 in total

1.  Use of unrestrained, single-chamber barometric plethysmography to evaluate sensitivity to cholinergic stimulation in mouse models of allergic airway disease.

Authors:  Fred D Finkelman
Journal:  J Allergy Clin Immunol       Date:  2008-01-04       Impact factor: 10.793

2.  Inhibitory effects of Schizandrae Fructus on eotaxin secretion in A549 human epithelial cells and eosinophil migration.

Authors:  Bang-gul Oh; Heekyung Lee; Yangseok Kim; Minkyu Shin; Moochang Hong; Sung-Ki Jung; Jinju Kim; Hyunsu Bae
Journal:  Phytomedicine       Date:  2009-03-25       Impact factor: 5.340

3.  Paeoniflorin suppresses inflammatory mediator production and regulates G protein-coupled signaling in fibroblast-like synoviocytes of collagen induced arthritic rats.

Authors:  L L Zhang; W Wei; N P Wang; Q T Wang; J Y Chen; Y Chen; H Wu; X Y Hu
Journal:  Inflamm Res       Date:  2008-08       Impact factor: 4.575

4.  Antiallergic effect of the root of Paeonia lactiflora and its constituents paeoniflorin and paeonol.

Authors:  Bomi Lee; Yong-Wook Shin; Eun-Ah Bae; San-Jun Han; Joo-Sun Kim; Sam-Sik Kang; Dong-Hyun Kim
Journal:  Arch Pharm Res       Date:  2008-05-01       Impact factor: 4.946

5.  Paeoniflorin inhibits systemic inflammation and improves survival in experimental sepsis.

Authors:  Wang-Lin Jiang; Xi-Guang Chen; Hai-Bo Zhu; Yu-Bai Gao; Jing-Wei Tian; Feng-Hua Fu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2009-04-03       Impact factor: 4.080

Review 6.  Efficacy and mechanisms of action of traditional Chinese medicines for treating asthma and allergy.

Authors:  Xiu-Min Li; Laverne Brown
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

7.  Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases.

Authors:  Jeroen A J Vanoirbeek; Manuela Rinaldi; Vanessa De Vooght; Steven Haenen; Sonja Bobic; Ghislaine Gayan-Ramirez; Peter H M Hoet; Erik Verbeken; Marc Decramer; Benoit Nemery; Wim Janssens
Journal:  Am J Respir Cell Mol Biol       Date:  2009-04-03       Impact factor: 6.914

8.  Suppression of cytokine expression by roflumilast and dexamethasone in a model of chronic asthma.

Authors:  C Herbert; A Hettiaratchi; D C Webb; P S Thomas; P S Foster; R K Kumar
Journal:  Clin Exp Allergy       Date:  2008-02-26       Impact factor: 5.018

9.  Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways.

Authors:  Katia De Filippo; Robert B Henderson; Melanie Laschinger; Nancy Hogg
Journal:  J Immunol       Date:  2008-03-15       Impact factor: 5.422

Review 10.  Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds.

Authors:  Marjan Nassiri Asl; Hossein Hosseinzadeh
Journal:  Phytother Res       Date:  2008-06       Impact factor: 5.878

View more
  2 in total

1.  Anti-asthmatic activities of an ethanol extract of Aster yomena in an ovalbumin-induced murine asthma model.

Authors:  Ji Hyun Sim; Hyun Seung Lee; Sunkyung Lee; Dae Eun Park; Keunhee Oh; Kyung-A Hwang; Hye-Ryun Kang; Sang-Kyu Ye; Hang-Rae Kim
Journal:  J Med Food       Date:  2014-04-16       Impact factor: 2.786

2.  Xiaoqinglong granules as add-on therapy for asthma: latent class analysis of symptom predictors of response.

Authors:  Qinglin Zha; Seqi Lin; Chi Zhang; Christopher Chang; Hanrong Xue; Cheng Lu; Miao Jiang; Yan Liu; Zuke Xiao; Weiyou Liu; Yunfei Shang; Jianjian Chen; Minyong Wen; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-03       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.